•
Dec 31, 2013

PTC Therapeutics Q4 2013 Earnings Report

Total Revenue
$4.41M
Previous year: $5.92M
-25.5%
EPS
-$0.75
Previous year: $37.4
-102.0%
Cash and Equivalents
$15.4M
Previous year: $2.73M
+465.4%
Total Assets
$152M
Previous year: $13.1M
+1062.0%

PTC Therapeutics

PTC Therapeutics